Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ESVIEF
- Development stage
- Unknown
- Lead developer
- Nearmedic Plus
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
ESVIEF is a topical hair and scalp care product developed by the Russian pharmaceutical company Nearmedic Plus. It is formulated as a lotion-tonic designed to address hair loss (alopecia), stimulate hair growth, and improve the overall structure and strength of the hair shaft. The product contains a complex of essential microelements and biostimulants, including mineral salts of zinc, copper, and manganese, which are intended to nourish hair follicles and improve scalp health. While marketed by a pharmaceutical company, ESVIEF is typically categorized as a parapharmaceutical or cosmetic biostimulant rather than a prescription pharmaceutical drug.
- Brand names
- ESVIEFЭсвиеф
- Other names
- ESVIEF-Nearmedic Plus
Beyond the preview
Go deeper on ESVIEF.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ESVIEF.